» Articles » PMID: 37591884

P21-activated Kinase 4 Suppresses Fatty Acid β-oxidation and Ketogenesis by Phosphorylating NCoR1

Overview
Journal Nat Commun
Specialty Biology
Date 2023 Aug 17
PMID 37591884
Authors
Affiliations
Soon will be listed here.
Abstract

PPARα corepressor NCoR1 is a key regulator of fatty acid β-oxidation and ketogenesis. However, its regulatory mechanism is largely unknown. Here, we report that oncoprotein p21-activated kinase 4 (PAK4) is an NCoR1 kinase. Specifically, PAK4 phosphorylates NCoR1 at T1619/T2124, resulting in an increase in its nuclear localization and interaction with PPARα, thereby repressing the transcriptional activity of PPARα. We observe impaired ketogenesis and increases in PAK4 protein and NCoR1 phosphorylation levels in liver tissues of high fat diet-fed mice, NAFLD patients, and hepatocellular carcinoma patients. Forced overexpression of PAK4 in mice represses ketogenesis and thereby increases hepatic fat accumulation, whereas genetic ablation or pharmacological inhibition of PAK4 exhibites an opposite phenotype. Interestingly, PAK4 protein levels are significantly suppressed by fasting, largely through either cAMP/PKA- or Sirt1-mediated ubiquitination and proteasome degradation. In this way, our findings provide evidence for a PAK4-NCoR1/PPARα signaling pathway that regulates fatty acid β-oxidation and ketogenesis.

Citing Articles

PAK4 promotes the cytoskeletal organization and meiotic maturation via phosphorylating DDX17 in oocyte.

Wang H, Gao M, Cheng Q, Zhu S, Chen Y, Gu L Cell Commun Signal. 2025; 23(1):85.

PMID: 39948582 PMC: 11827469. DOI: 10.1186/s12964-025-02085-3.


PAK4 Is Involved in the Stabilization of PD-L1 and the Resistance to Doxorubicin in Osteosarcoma and Predicts the Survival of Diagnosed Patients.

Zhang J, Song Y, Ahn A, Park H, Park S, Moon Y Cells. 2024; 13(17.

PMID: 39273017 PMC: 11394300. DOI: 10.3390/cells13171444.


PAK4 phosphorylates and inhibits AMPKα to control glucose uptake.

Wu D, Chan Yu H, Cha H, Park S, Lee Y, Yoon S Nat Commun. 2024; 15(1):6858.

PMID: 39127697 PMC: 11316743. DOI: 10.1038/s41467-024-51240-w.


p21-activated kinase 4 counteracts PKA-dependent lipolysis by phosphorylating FABP4 and HSL.

Chan Yu H, Jeon Y, Na A, Han C, Lee M, Yang J Nat Metab. 2024; 6(1):94-112.

PMID: 38216738 DOI: 10.1038/s42255-023-00957-x.

References
1.
Fletcher J, Deja S, Satapati S, Fu X, Burgess S, Browning J . Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver. JCI Insight. 2019; 5. PMC: 6629163. DOI: 10.1172/jci.insight.127737. View

2.
Satapati S, Sunny N, Kucejova B, Fu X, He T, Mendez-Lucas A . Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J Lipid Res. 2012; 53(6):1080-92. PMC: 3351815. DOI: 10.1194/jlr.M023382. View

3.
Won S, Park J, You S, Hyeun J, Kim H, Jin B . p21-activated kinase 4 controls the aggregation of α-synuclein by reducing the monomeric and aggregated forms of α-synuclein: involvement of the E3 ubiquitin ligase NEDD4-1. Cell Death Dis. 2022; 13(6):575. PMC: 9247077. DOI: 10.1038/s41419-022-05030-1. View

4.
Mottis A, Mouchiroud L, Auwerx J . Emerging roles of the corepressors NCoR1 and SMRT in homeostasis. Genes Dev. 2013; 27(8):819-35. PMC: 3650221. DOI: 10.1101/gad.214023.113. View

5.
Sengupta S, Peterson T, Laplante M, Oh S, Sabatini D . mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature. 2010; 468(7327):1100-4. DOI: 10.1038/nature09584. View